METABOLIC EFFECTS OF THE TRIPHASIC ORAL-CONTRACEPTIVE TRIGYNONR

被引：45

作者：

VERMEULEN, A ^{[1
]}

THIERY, M ^{[1
]}

机构：

[1] STATE UNIV GHENT, ACAD ZIEKENHUIS, DEPT OBSTET & GYNAECOL, MED CLIN, B-9000 GHENT, BELGIUM

来源：

CONTRACEPTION | 1982年 / 26卷 / 05期

关键词：

D O I：

10.1016/0010-7824(82)90149-4

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

收藏

页码：505 / 513

页数：9

相关论文

共 37 条

[1] AURELL M, 1966, LANCET, V1, P291
[2] BOY J, 1966, ANN BIOL CLIN, V18, P669
[3] SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN WOMEN USING ORAL-CONTRACEPTIVES, ESTROGENS AND PROGESTINS
BRADLEY, DD
WINGERD, J
PETITTI, DB
KRAUSS, RM
RAMCHARAN, S
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (01) : 17 - 20
[4] BRIGGS MH, 1982, BENEFITS RISKS HORMO
[5] EFFECT OF STEROIDAL CONTRACEPTIVES ON LEVELS OF PLASMA ANDROGEN SULFATES AND CORTISOL
BULBROOK, RD
HERIAN, M
TONG, D
HAYWARD, JL
SWAIN, MC
WANG, DY
[J]. LANCET, 1973, 1 (7804) : 628 - 631
[6] CAROL W, 1980, ENDOKRINOLOGIE, V75, P167
[7] EVIDENCE FOR AN INFLUENCE OF THE OVARY ON CIRCULATING DEHYDROEPIANDROSTERONE SULFATE LEVELS
CUMMING, DC
REBAR, RW
HOPPER, BR
YEN, SSC
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (05) : 1069 - 1071
[8] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[9] FURMAN R H, 1967, Progress in Biochemical Pharmacology, V2, P215
[10] GOLDMAN JA, 1969, AM J OBSTET GYNECOL, V103, P172

← 1 2 3 4 →